Specialty	Internal Medicine
Clinical Interests	Atrial Fibrillation
	Preventive Medicine
	Primary Care
	Thrombosis
Gender	Male
E-mail	andrew.dunn@mountsinai.org
Education and Training	MD, New York University
	Residency, Internal Medicine, Mount Sinai Hospital
	Internship, Internal Medicine, Mount Sinai Hospital
Awards	2001 House Staff Ambulatory Preceptor Award

\tDr. Andrew Dunn graduated for New York University Medical School in 1992, and completed a residency in internal medicine at The Mount Sinai Medical Center in 1995. Dr. Dunn remained at Mount Sinai as a member of the faculty in the Division of General Medicine, and is currently a Practice Chief in the General Medicine Clinic and Director of the Primary Care Anticoagulation Service. His primary area of clinical and research interest is anticoagulation and thrombosis. Dr. Dunn has developed and directs an innovative program to facilitate home treatment of deep vein thrombosis. He has given numerous lectures in this field, including a workshop at a National meeting of the Society of General Internal Medicine. In addition, he has presented his research at regional and national meetings, and published several articles on this topic. He is currently a principal investigator for randomized trials of a novel anticoagulant for the treatment of deep vein thrombosis and pulmonary embolism, as well as leading an investigation of the use of low-molecular-weight heparin for perioperative anticoagulation for patients on long-term warfarin.

Clinical Interests

• Anticaogulation and Thrombosis
• Outpatient Deep Vein Thrombosis Treatment
• Mathematical Modelling of Warfarin Dose Adjustments

Clinical Programs

• Director, The Mount Sinai Hospital Outpatient DVT Treatment Program
• Director, Early Discharge on Warfarin Program
• Community Acquired Pneumonia Clinical Pathways Project
• Director, Primary Care Anticoagulation Service

Education and Training	MD, New York University
	Residency, Internal Medicine, Mount Sinai Hospital
	Internship, Internal Medicine, Mount Sinai Hospital
Board Certification	Internal Medicine

Specialty	Internal Medicine
Clinical Interests	Atrial Fibrillation
	Preventive Medicine
	Primary Care
	Thrombosis
Board Certification	Internal Medicine

Anticoagulation and thrombosis, including prophylaxis and treatment of DVT and PE, and perioperative management of warfarin

Research Projects

• Site Director, Peripheral Arterial Disease Detection Project (PAD PARTNERS) - Director for one of 15 sites in a multicenter trial of peripheral arterial disease screening.
• Site Director, MATISSE DVT and PE trials. International randomized trials of DVT and PE treatment.
• Principal Investigator - Outpatient DVT Treatment Using LMWH. Prospective cohort study of outpatient DVT treatment with LMWH.
• Principal Investigator - Mathematical Modeling of Warfarin Dose. Derivation and validation of a model for warfarin dosage adjustments.
• Principal Investigator - Effect of Warfarin Titration on Delay of Discharge.
• Principal Investigator - The Use of Low-molecular-weight Heparin in the Perioperative Period for Patients on Long-term Warfarin.

Dunn A, Silver A. Assigning Faculty as Attendings for Inpatients Not Covered by Housestaff Increased Housestaff Satisfaction. J Gen Intern Med 1996; 11: 68.

Dunn A. Autosomal/Recessive: Familial Hypocalciuric Hypercalcemia. Ann Intern Med 1997; 126: 835.

Malik T, Brod-Miller C, Dunn A, Edelman L, Feit E, Orbuch M. Physical Diagnostic Signs in Critical Care Medicine. In: Cunha. Infectious Disease in Critical Care Medicine; 1998. pp67-117.

Orbuch M, Dunn AS. Considerations in the abdominal examination. In: Malik T, editor. Infectious Diseases in Critical Care Medicine. New York, Marcel Dekker, Co.; 1998.

Dunn A, Shridharani K, Bernstein R, Horowitz C. Physician-Patient Discussions of Controversial Cancer Screening Tests. J Gen Intern Med 1999; 14: 25.

Dunn A, Peterson KL, Schechter CB, Rabito P, Gotlin AD, Smith LG. . The Utility of an In-Hospital Observation Period After Discontinuing Intravenous Antibiotics. Amer J Med 1999; 1: 6-10.

Dunn A, Coller B. Outpatient Deep Vein Thrombosis Treatment: Translating Clinical Trials Into Practice. Amer J Med 1999; 106: 660-669.

Dunn A, Schechter CB, Latzman B, Halperin JL. A Mathematical Model to Adjust Warfarin Dose During Chronic Anticoagulation. . J Gen Intern Med 2000; 15: 62.

Kassaye SG, Morrison DE, Dunn A. The Need to Consider Cystic Fibrosis in Adults with Unexplained Elecrolyte Abnormalities. J Gen Intern Med 2000; 15: 184.

Dunn A. Oral Heparin. IDrugs 2000; 3: 817-824.

Dunn AS, Turpie AG G. Perioperative management of patients on oral anticoagulants: a systematic review. Arch Intern Med 2003; 163: 901-908.

Dunn AS, Bioh D, Beran M, Capasso M, Siu AL. The impact of intravenous heparin administration on duration of hospitalization. Mayo Clinic Proc 2004; 79: 159-163.

Dunn AS. Perioperative management of patients on oral anticoagulation. Cardiovasc Rev and Rep 2004; 25: 208-211.

Kaboli PJ, Brenner A, Dunn AS. Prevention of venous thromboembolism in medical and surgical patients. Clev Clin J Med 2005; 72(Supplement 1): S7-S13.

Dunn AS, Ho W, Wisnivesky J, Moore C, Mcginn T, Sacks HS. Perioperative management of patients on oral anticoagulants: a decision-analysis. Medical Decision-Making 2005; 25: 387-397.

Dunn AS, Kaboli P, Halfdanarson T, Chan H, Hubert R, White RH. Do patients followed in anticoagulation clinics for antiphospholipid antibody syndrome meet criteria for the disorder?. Thromb Haem 2005; 94: 548-554.

Dunn AS. The revised Geneva score predicted pulmonary embolism in patients with shortness of breath or chest pain. ACP J Club 2006; 145: 25.

Dunn AS. Perioperative management of oral anticoagulation: when and how to bridge. J Thromb Thrombolysis 2006; 21: 85-89.

Dunn AS, Brenner A , Halm E . The magnitude of an iatrogenic disorder: A systematic review of the incidence of venous thromboembolism for general medical inpatients . Thromb Haem 2006; 95: 758-62.

Lin JJ, Moore C, Dunn AS. Follow-up of outpatient test results: a survey of housestaff practices and perceptions. Am J Med Qual 2006; 21: 178-184.